[HTML][HTML] Nanostructured lipid carriers for delivery of chemotherapeutics: A review

M Haider, SM Abdin, L Kamal, G Orive - Pharmaceutics, 2020 - mdpi.com
The efficacy of current standard chemotherapy is suboptimal due to the poor solubility and
short half-lives of chemotherapeutic agents, as well as their high toxicity and lack of …

Nanostructured lipid carriers (NLCs) for drug delivery and targeting

CL Fang, SA Al-Suwayeh… - Recent patents on …, 2013 - ingentaconnect.com
Nanostructured lipid carriers (NLCs) are drug-delivery systems composed of both solid and
liquid lipids as a core matrix. It was shown that NLCs reveal some advantages for drug …

[PDF][PDF] Metabolism and disposition of prescription opioids: a review

AZ DePriest, BL Puet, AC Holt… - Forensic Sci …, 2015 - forensicsciencereview.com
Opioid analgesics are commonly prescribed for acute and chronic pain, but are subject to
abuse. Consequently, toxicology testing programs are frequently implemented for both …

Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection

JJ Wang, KS Liu, KC Sung, CY Tsai, JY Fang - European Journal of …, 2009 - Elsevier
Buprenorphine is a promising drug for the treatment of chronic pain and opioid dependence.
The aim of the present work was to evaluate the feasibility of lipid nanoparticles with different …

Interpreting quantitative urine buprenorphine and norbuprenorphine levels in office-based clinical practice

JH Donroe, SR Holt, PG O'Connor, N Sukumar… - Drug and alcohol …, 2017 - Elsevier
Background Quantitative urine buprenorphine testing is used to monitor patients receiving
buprenorphine for the treatment of opioid use disorder (OUD), however the interpretation of …

Opioid treatment for neonatal opioid withdrawal syndrome: current challenges and future approaches

BT McPhail, C Emoto, D Butler… - The Journal of …, 2021 - Wiley Online Library
Chronic intrauterine exposure to psychoactive drugs often results in neonatal opioid
withdrawal syndrome (NOWS). When nonpharmacologic measures are insufficient in …

[HTML][HTML] An examination of the complex pharmacological properties of the non-selective opioid modulator buprenorphine

LJ Pande, RE Arnet, BJ Piper - Pharmaceuticals, 2023 - mdpi.com
The goal of this review is to provide a recent examination of the pharmacodynamics as well
as pharmacokinetics, misuse potential, toxicology, and prenatal consequences of …

Buprenorphine-related deaths in North Carolina from 2010 to 2018

SC Bishop-Freeman, LW Friederich… - Journal of Analytical …, 2021 - academic.oup.com
Buprenorphine (BUP) is a commonly prescribed medication for the treatment of opioid use
disorder (OUD). As prescriptions increase in North Carolina, BUP is more frequently …

Buprenorphine-induced hyperalgesia in the rat

EP Wala, JR Holtman Jr - European journal of pharmacology, 2011 - Elsevier
In addition to analgesia opioids may also enhance pain sensitivity. Opioid-induced
hyperalgesia, typically associated with potent mu-opioid agonists (eg fentanyl, morphine …

[HTML][HTML] Analytical approaches for the determination of buprenorphine, methadone and their metabolites in biological matrices

X Shan, C Cao, B Yang - Molecules, 2022 - mdpi.com
The abuse of buprenorphine and methadone has grown into a rising worldwide issue. After
their consumption, buprenorphine, methadone and their metabolites can be found in the …